We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
-3.24%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$316M
AUM Growth
-$18.4M
Cap. Flow
+$10.7M
Cap. Flow %
3.39%
Top 10 Hldgs %
70.86%
Holding
143
New
8
Increased
19
Reduced
19
Closed
12

Sector Composition

Rank Sector Weight
1 Communication Services 43.73%
2 Consumer Discretionary 17.69%
3 Healthcare 12.36%
4 Energy 4.3%
5 Industrials 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.08T
$83.1M 26.3%
1,913,500
+399,720
+26% +$23.1M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.07T
$51M 16.12%
943,100
AMZN icon
3
Amazon
AMZN
$2.48T
$21.8M 6.89%
230,080
-240
-0.1% -$22.4K
LZB icon
4
La-Z-Boy
LZB
$1.65B
$18.5M 5.86%
604,435
RGNX icon
5
Regenxbio
RGNX
$615M
$12.7M 4.02%
247,337
+6,600
+3% +$330K
AMLP icon
6
Alerian MLP ETF
AMLP
$12.9B
$10.6M 3.37%
216,000
-600
-0.3% -$29.7K
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$8.24M 2.61%
156,635
+14,950
+11% +$859K
BABA icon
8
Alibaba
BABA
$276B
$6.91M 2.19%
40,800
DMLP icon
9
Dorchester Minerals
DMLP
$1.3B
$5.63M 1.78%
307,630
-750
-0.2% -$14.1K
SPY icon
10
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$5.41M 1.71%
18,382
CW icon
11
Curtiss-Wright
CW
$26.9B
$5.33M 1.68%
41,839
-200
-0.5% -$23K
GPC icon
12
Genuine Parts
GPC
$17.9B
$5M 1.58%
47,940
-47,900
-50% -$4.96M
EEM icon
13
iShares MSCI Emerging Markets ETF
EEM
$28B
$4.71M 1.49%
109,798
-1,000
-0.9% -$42.5K
TMO icon
14
Thermo Fisher Scientific
TMO
$214B
$4.68M 1.48%
15,934
ATVI
15
DELISTED
Activision Blizzard
ATVI
$4.2M 1.33%
89,046
-350
-0.4% -$16.1K
DBL
16
DoubleLine Opportunistic Credit Fund
DBL
$278M
$3.86M 1.22%
184,415
SRPT icon
17
Sarepta Therapeutics
SRPT
$1.63B
$3.68M 1.16%
24,234
+2,500
+12% +$304K
AMJ
18
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$3.64M 1.15%
145,000
RDS.B
19
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$3.27M 1.03%
49,688
NBIX icon
20
Neurocrine Biosciences
NBIX
$18.4B
$3.25M 1.03%
38,521
-625
-2% -$51.3K
GREK
21
Global X MSCI Greece ETF
GREK
$291M
$2.85M 0.9%
98,767
+367
+0.4% +$9.51K
MRK icon
22
Merck
MRK
$326B
$2.73M 0.86%
33,846
-35,755
-51% -$2.74M
MO icon
23
Altria Group
MO
$125B
$2.54M 0.8%
52,722
-555
-1% -$29.1K
XES icon
24
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$357M
$2.21M 0.7%
23,000
EFA icon
25
iShares MSCI EAFE ETF
EFA
$76.8B
$1.93M 0.61%
29,350

Similar funds

ArchPoint Investors's Q2 2019 Portfolio in Review

As of Q2 2019, ArchPoint Investors held 143 positions worth $316M, down 5.5% from $334M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

ArchPoint Investors deployed $10.7M of net new capital in Q2 2019, opening 8 new positions and adding to 19 existing holdings. Its largest new stake was Niu Technologies: 174,848 shares worth $1.03M.

By sector, the portfolio is most concentrated in Communication Services at 44% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Genuine Parts, an estimated $4.96M trimmed.

  • ArchPoint Investors's largest Q2 2019 buy was Niu Technologies: 174,848 shares worth $1.03M.
  • ArchPoint Investors added most to Alphabet (Google) Class A in Q2 2019, an estimated $23.1M increase.
  • ArchPoint Investors's biggest Q2 2019 reduction was Genuine Parts, cutting an estimated $4.96M.
  • ArchPoint Investors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2019, selling an estimated $2.62M.
  • ArchPoint Investors's ten largest holdings make up 71% of its $316M portfolio in Q2 2019.
  • ArchPoint Investors opened 8 new positions and closed 12 in Q2 2019.
  • ArchPoint Investors's portfolio value fell 5.5% quarter-over-quarter to $316M.

Based on ArchPoint Investors's 13F filing for Q2 2019, filed 26 Jul 2019.